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LP CSIC/UAB
is a laboratory of
Human T-lymphocyte phosphoproteome, a model for the study
of signal transduction and the altered immune response.
The T-lymphocyte phosphoproteome
 There is not available information about p-sites in these cells.
 The only related data available are from Jurkat T cell lines and describes mainly 
tyrosine phosphorylation.
 Knowlegde of phosphorylation processes in primary T-cells is principal for the 
understanding of immune response.
 Characterization of phosphorylation motifs is the first step for the identification of new 
kinases of physiological relevance. 
Unravel the changes in the phosphoproteome of human primary T-
lymphocytes using mass spectrometry-based proteomics to define new
phosphorylation substrates in the cellular response.
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MIAPE INFO: SAMPLE PREPARATION AND HANDLING
This guideline describes parameters and conditions involved in phosphopeptide sample
preparation. It covers from the description and preparation of the cells and tissues to the fractionation
and specific enrichment of phosphopeptides for MS analysis. The guideline is prepared in order to
easily cope with many of the experimental designs used in phosphoproteomic studies.
Sample Preparation and handling
1.- General features
2.- Sample processing
3.- Protein Purification/Fractionation
4.- Peptide Purification/Fractionation
5.- Phosphopeptide enrichment
Sample Preparation for Phosphoproteomics
 Classification Definition 
1. General features 
1.1 
Date stamp (as yyyy-mm-
dd) 
The date on which the work described was 
initiated; given in the standard yyyy-mm-dd 
format (with hyphens) 
1.2 
Responsible person or 
institutional role 
The (stable) primary contact person for this data 
set: this could be the experimenter, lab head, line 
manager, etc. Where responsibility rest with an 
institutional role (e.g. One of a number of duty 
officers) rather than a person, give the official 
name of the role rather than any one person. In 
all cases give affiliation and stable contact 
information, which consists of (i) Name, (ii) Postal 
address and (iii) Email address. 
1.3 Sample/s name/s 
Name of the samples processed. Include if there 
are control, standard of test samples and if 
samples are a pool of different individual. 
1.4 Replicates Number of replicates of the experiment. 
 
Sample Preparation and handling
1.- General features
2.- Sample processing
3.- Protein Purification/Fractionation
4.- Peptide Purification/Fractionation
5.- Phosphopeptide enrichment
MIAPE INFO: SAMPLE PREPARATION AND HANDLING
1.- en r l
If possible, we used definitions
previously described.
New definitions are added to
implement new features.
Cell /Tissue
Handling
Cells
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Culture parameters
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Pellet preparation
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Other procedures
Tissue disruption
Other procedures
Protein Deplection
Other procedures
MIAPE INFO: SAMPLE PREPARATION AND HANDLING
Sample Preparation and handling
1.- General features
2.- Sample processing
3.- Protein Purification/Fractionation
4.- Peptide Purification/Fractionation
5.- Phosphopeptide enrichment
2.- Sample P ing
Protein 
digestion
Peptide/Protein 
Labelling
Other
treatments
Protein 
precipitation
Pretreatment
Digestion parameters
Reagents and conditions
Redisolution buffer
Type of leballing
Customizations
 Critical part of the experiment.
 Include the description and preparation of 
samples from biological material to protein extract. 
We include sections for cell ,tissue and fluid 
handling. 
2. Sample Processing 
2.1 Culture/tissue handling   
 Tissue/Cell/Fluid type Biological material used in the experiment.  
 
Source 
Source from which the material is obtained (e.g. T-cells 
from buffy coat) 
 Species Species of procedence 
 Isolation/Collection Method 
Surgical procedure, laser capture, intravenous blood 
extraction, etc 
2.1.1 Cells  
2.1.1.1 Cell Isolation Method 
Method used for cell isolation (e.g. Ficoll-Paque T-cells 
purification from buffy coat, enzymatic digestion, explant 
culture...) 
2.1.1.2 Culture parameters   
 Culture medium Growth medium with all the complements added 
 
Culture conditions 
Temperature and gas mixture (typically for mammalian 
cells, 37ºC, 5% CO2) 
 Cell density Number of cells per mL 
 
Type of culture 
Indicate if there are suspension or adherent cells and if 
they are primary cultures 
 
Time of culture 
Time which the cells are in culture and number of previous 
passages. 
2.1.1.3 Cell treatment   
 Starting Amount Number of cells submitted to treatment 
 
Culture medium 
Culture medium for activation with all the complements 
added 
 Culture conditions Temperature and gas mixture used for treatment 
 
Cell Treatment 
Cell treatment (activator,drug). Include concentration and 
buffers used for addition 
 Cell density Number of cells per mL during treatment 
 
1D SDS-PAGE and 
in-gel digestion
Gel matrix and electrophoresis
(HUPO-PSI GE vs.1.4)
Staining
(HUPO-PSI GE vs.1.4)
In-gel digestion
HPLC and liquid 
digestion
Equipment
(HUPO-PSI CC vs.1.0
Liquid digestions of fractions
(if required)
Other parameters
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Sample Preparation and handling
1.- General features
2.- Sample processing
3.- Protein Purification/Fractionation
4.- Peptide Purification/Fractionation
5.- Phosphopeptide enrichment
3.- Protein Purifi / ractionation
In sections where the methodology described
has been already documented as part of other
MIAPEs (1D SDS-PAGE and HPLC purifications),
the corresponding sections have been imported
from them. Thus, this proposal includes some
definitions from HUPO-PSI Gel Electrophoresis
vs. 1.4, January 2008 and Column
Chromatography vs. 1.0, June 2008 documents.
HPLC separation
Equipment
(HUPO-PSI CC vs.1.0
Other parameters
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Sample Preparation and handling
1.- General features
2.- Sample processing
3.- Protein Purification/Fractionation
4.- Peptide Purification/Fractionation
5.- Phosphopeptide enrichment
4.- Peptide Purific ci n/Fractionation
Peptide separation by HPLC are also adapted
from HUPO-PSI CC vs. 1.0.
Peptide separation by IEF using OFFGEL
fractionation is implemented.
Peptide separation 
by pI (OFFGEL)
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Procedure
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Phosphopeptide
extract 1
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Phosphopeptide
extract 2TiO2
enrichment
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IMAC 
enrichment
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Sequential IMAC/TiO2
extractions
Thingholm et al, 2008
Carrascal et al, 2008
-IMAC       phosphate affinity for metals
-TiO2       acid/base interactions
Different selectivities
(Bodenmiller 2007)
LC-MS 
analysis
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Sample Preparation and handling
1.- General features
2.- Sample processing
3.- Protein Purification/Fractionation
4.- Peptide Purification/Fractionation
5.- Phosphopeptide enrichment5.- Phospho  richment
Usually, different and complementary
methods are used (p.e. IMAC and TiO2).
If procedures are repeated more than
once, the corresponding section should
be repeated.
5. Phosphopeptide Enrichment  (Repeat the steps as necessary) 
5.1 Method 1   
 Method description Brief description of the method (e.g. IMAC purification) 
5.1.1 Starting sample  
 Origin of the sample 
The origin of the peptide mixture submitted to purification: 
solution from in-gel digestion, eluate from HPLC or other 
peptide enrichment procedure, etc 
 Volume Initial volume of the peptide mixture to be purified 
 Pretreatment Volume reduction, sample dilution, dessalting, etc... 
 Loading buffer 
Buffer (type and volume) used to dissolve or dilute the 
sample and to load it into the resin 
5.1.2 Affinity material  
 
Description of the affinity 
material 
Material used for phosphopeptide enrichment. Include 
name of the manufacturer, reference and, if required, type 
of metal loaded in the material . 
 
Pretreatment of the affinity 
material 
Procedures used to suspend, wash and conditionate the 
affinity material (buffers, time and volume). 
5.1.3 Affinity purification procedure  
 Volume of sample Volume of sample used for purification (in SI units). 
 Amount of affinity material 
Amount of affinity material used for purification (in SI 
units). 
 Type of purification 
In-batch or in-column purification (indicate the type of 
tube, holder or other container used for the purification). 
 Incubation time Incubation time of the sample with the resin 
 Incubation temperature Incubation temperature of the sample with the resin 
 Washing buffer 
Buffer (type and volume) used to wash the affinity material 
after incubation. 
 Elution buffer 
Buffer (type and volume) used to elute the 
phosphopeptides from the resin. 
 Name of the obtained fractions 
Code identifying the eluted extract and/or. if appropiate, 
the unretained fraction to be submitted to other analyses. 
5.1.4 Other parameters Other parameters not included in 5.1.1 to 5.1.3. 
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A. Information related to each data entry: scan 
number, phos-file name, raw file name, scores 
and a condition id.
B. MIAPE documents related to each data entry.
p.e. condition id = 1 is associated with an
“SDS-PAGE Titanium Resting Lymphocytes”
experiment, with 3 associated MIAPE
documents: Sample Preparation, Mass
Spectrometry and MS informatics.
C. Each data entry is associated with a spectrum in
the spectra table.
D. Associates each data entry with the phosphosites
characterized in the peptide, the proteins
mapped by this peptide and the position of the
phosphate in the protein sequence.
E. Full set of proteins mapped by the phospho-
peptides in the LymPHOS database.
F. Relates each data entry (every peptide) with one or
more proteins.MIAPE INFO
Joaquín Abián 2008, LP CSIC/UAB
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Sample Preparation and handling
1.- General features
2.- Sample processing
3.- Protein Purification/Fractionation
4.- Peptide Purification/Fractionation
5.- Phosphopeptide enrichment
MIASPPE
1.- Protein extracts preparation from cell culture, tissues and flui ds
2.- Protein digestion (in- gel and liquid).
3.- Protein/peptide labelling
4.- Phosphopeptide enrichment
Protein Purification/Fractionation: HUPO - PSI Gel 
Electrophoresis vs. 1.4, January 2008 and Column 
Chromatography vs. 1.0, June 2008 documents
Peptide Purification/Fractionation: HUPO - PSI Gel 
Electrophoresis vs. 1.4, January 2008 and Column 
Chromatography vs. 1.0, June 2008 documents
MIAPE proposal forms
MIASPPE  MIAPE
 To adapt this guideline to a MIAPE document it has been considered more
convenient to modularize its contents.
 The MIASPPE has been divided in 6 sections from where 4 different proposal
forms have been prepared.
 Two other sections are already covered by existing HUPO-PSI documents.
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MIAPE proposal form for Peptide Labeling
1. General features
1.1 Date stamp (as yyyy-mm-dd) 23/02/2010
1.2 Responsible person or institutional role M.Carrascal. LP-CSIC/UAB
1.3 Sample/s name/s Control and 4-hours activated lymphocytes
1.4 Replicates 2
2. Peptide Labeling
2.1 General
2.1.1 Type of labeling
2.1.2 Significative customizations -
2.1.3 Other treatments -
2.2 Sample Labelling
2.2.1 Reagent 1
Reporter ion
Sample ID
2.2.2 Reagent 1
Reporter ion
Sample ID
2.2.3 Reagent 1
Reporter ion
Sample ID
2.2.4 Reagent 1
Reporter ion
Sample ID
2.3 Sample identification
2.3.1 Sample 1 Non-activated T-cells
2.3.2 Sample 2 Non-activated T-cells
2.3.3 Sample 3 4-hours PMA activated T-cells
2.3.4 Sample 4 4-hours PMA activated T-cells
 MIAPE for Peptide Labeling
  Proposal vs 1.0 (11/03/2010)
Name
New LymPHOS workflow
Sequest OMSSA Phenyx
Thermo 
RAW file
XDK
Extract_msn
mgf creator
mgf file
phosFile
Consensus protein list
P34931(39)|P08107(37)|P54652(38)|P17066(39)
Fasta DB
Consensus deltamz
Ascore
(phospho-DH-itraq)
iTRAQ info
Reporting / Lymphos database
New LymPHOS workflow
phosFile
MIAPE 
info
LymPHOS
DB
Peak lists generation (mgf) ← MS-MIAPE
Search engines (Sequest,OMSSA) ← MSi-MIAPE
Ascore calculation ← MSi-MIAPE 
Quantitative info (iTRAQ,TMT) ← MIAPE for Protein/Peptide Labeling
Protein assignation ← MSi-MIAPE
Data Processing
MIAPE info can be used to process data.
A controlled vocabulary is essential
Obtained data is stored in a phosfile
. Processing and analysis tunning and optimization 
. Data comparison between different experimental conditions
Data Analysis
Complex analysis can be done using the information st red in Lympho  dat base and 
using the phosfile and MIAPE information in a collaborative way. Some examples:
Phosphosite quantitative analysis.
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phosFile: Complex Reporting
CONCLUSIONS AND FUTURE
We develop four MIAPE proposals for Sample Preparation 
following the HUPO-PSI standards.
We create a dynamic interaction between our workflow and the 
MIAPE for the quantitative LC-MS studies.
We need your help to 
improve, correct and 
validate the 
documents ¡¡¡
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